The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome

Journal of Invasive Cardiology

Volumn 24, Issue 12, 2012, Pages 655-660

  Muschart, Xavier ^a   Slimani, Alisson ^a   Jamart, Jacques ^a   Chenu, Patrick ^a   Dangoisse, Vincent ^a   Gabriel, Laurence ^a   Guédès, Antoine ^a   Marchandise, Baudouin ^a   Schröder, Erwin ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

In hospital mortality; Mechanism of periprocedural MI; Periprocedural myocardial infarction

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPROCEDURAL MYOCARDIAL INFARCTION; STENT; STENT THROMBOSIS;

AGED; CORONARY OCCLUSION; CORONARY VESSELS; CREATINE KINASE, MB FORM; FEMALE; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871273292     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Eur Heart J. 2007;28(20 2525-2538
2. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005;26(23 2493-2519
3. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31(2 241-251
4. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation. 2001;104(6 642-647
5. Carrozza JP, Cutlip D, Levin T. Periprocedural complications of percutaneous coronary intervention. [Computer program]. Up to date; Accessed on May 2010-11-09
6. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011;364(5 453-464
7. Andron M, Stables RH, Egred M, et al. Impact of peri-procedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention. J Invasive Cardiol. 2008;20(3 108-112
8. Kelly D, Arora R. Prognostic significance of myocardial enzyme release after coronary interventions. Catheter Cardiovasc Interv. 1999;46(3 292-302
9. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis: Are spontaneous and percutaneous coronary intervention-related events different? Circulation. 2002;105(5 554-556
10. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol. 2000;35(5 1134-1141
11. Hanna EB, Hennebry TA. Periprocedural myocardial infarction: Review and classification. Clin Cardiol. 2010;33(8 476-483
12. Patti G, Pasceri V, Nusca A, Di Sciascio G. Prevention of peri-procedural myocardial damage in patients undergoing percutaneous coronary intervention. Ital Heart J Suppl. 2005;6(9 553-560
13. Pasceri V, Patti G, Di Sciascio G. Prevention of myocardial damage during coronary intervention. Cardiovasc Hematol Disord Drug Targets. 2006;6(2 77-83
14. Cavallini C, Savonitto S. Prognostic significance of the elevation of the indices of myocardial damage after percutaneous coronary revascularization interventions. Ital Heart J Suppl. 2002 Mar;3(3 270-274
15. Vrijens F, De Gauquier K, Camberlin C. Le volume des interventions chirurgicales et son impact sur le résultat: Étude de faisabilité basée sur des données belges. Good Clinical Practice (GCP). Bruxelles: Centre fédéral d'expertise des soins de santé (KCE); 2009. KCE reports 113B (D/2009/10.273/34).
16. Ioannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoensyme after percutaneous coronary intervention. J Am Coll Cardiol. 2003;42(8 1406-1411
17. Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ. Death following creatine kinase-MB elevation after coronary intervention: Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation. 2002;106(10 1205-1210
18. Jeremias A, Baim Ds, HO KK, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol. 2004;44(6 1210-1214
19. Balaguer-Malfagon JR, Pomar-Domingo F, Vilar-Herrero J, et al. Stent thrombosis in the modern era: Incidence, outcome and predictive factors. Rev Esp Cardiol. 2006;59(8 842-845
20. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol. 2002;40(11 1961-1967
21. Brener SJ, Ellis SG, Schneider JP, Topol EJ. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J. 2002;23(11 869-876
22. Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention. J Am Coll Cardiol. 1999;34(3 663-671
23. Novack V, Pencina M, Cohen DJ, et al. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med. 2012;172(6 502-508.